BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1233)

  • 1. Kinetic and spectral studies of type I and type II compounds with rat hepatic microsomes in the presence of the major metabolite of diphenylhydantoin.
    Stavchansky SA; Kostenbauder HB; Lubawy WC
    Drug Metab Dispos; 1975; 3(6):557-64. PubMed ID: 1233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the spectral interactions of fusarin C with rat liver microsomal cytochrome P-450.
    Gelderblom WC; Swart P; Kramer PS
    Xenobiotica; 1988 Sep; 18(9):1005-14. PubMed ID: 3227702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
    Augustine JA; Zemaitis MA
    Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic microsomal metabolism of drugs during pregnancy in the rat.
    Dean ME; Stock BH
    Drug Metab Dispos; 1975; 3(5):325-31. PubMed ID: 241612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of d-propoxyphene and diphenylhydantoin in rat liver microsomal preparation.
    Verebey K
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):21-9. PubMed ID: 663405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
    O'Leary TD; Sansom LN
    J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of experimental diabetes on drug metabolism in the rat.
    Ackerman DM; Leibman KC
    Drug Metab Dispos; 1977; 5(4):405-10. PubMed ID: 19220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of a hydrophobic site in the inhibition of the microsomal p-hydroxylation of aniline by alcohols.
    Cohen GM; Mannering GJ
    Mol Pharmacol; 1973 May; 9(3):383-97. PubMed ID: 4145468
    [No Abstract]   [Full Text] [Related]  

  • 16. Some observations on the type I and type II microsomal binding spectra.
    Gorrod JW; Disley LG; Temple DJ
    Xenobiotica; 1971; 1(4):521-2. PubMed ID: 5164847
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of dietary protein quality on drug metabolism in the rat.
    Miranda CL; Webb RE
    J Nutr; 1973 Oct; 103(10):1425-30. PubMed ID: 4745519
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dietary lipid on drug-metabolizing enzymes.
    Wade AE; Norred WP
    Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsomal O-demethylation, N-demethylation and aromatic hydroxylation in the presence of bisulfite and dithiothreitol.
    Smith RV; Erhardt PW; Leslie SW
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):181-4. PubMed ID: 1188185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
    Kaul KL; Novak RF
    J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.